This study is currently not recruiting participants.

Preliminary BrainPath Experience with Deep Intracerebral Neurological Surgery

Study on Minimally Invasive Investigational Intracerebral Access System

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to evaluate the safety and efficacy of preliminary experience with new minimally invasive intracerebral access system, with focus on intracerebral hermorrhage and deep intraparenchymal tumors.

Detailed description of study

The purpose of this study is to evaluate the safety and efficacy of preliminary experience with new minimally invasive intracerebral access system, with focus on intracerebral hermorrhage and deep intraparenchymal tumors.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Healthy
  • Age: 100 years or below
  • Gender: All

This study investigates the use of a minimally invasive system for accessing the brain. It focuses on conditions such as bleeding in the brain (intracerebral hemorrhage) and tumors located deep within the brain tissue (deep intraparenchymal tumors).

Participants in the study will undergo procedures using this new access system. The goal is to understand how safe and effective it is for reaching and treating these specific brain conditions.

  • Who can participate: Adults aged 18 and older with diagnosed intracerebral hemorrhage or deep intraparenchymal tumors may be eligible to participate.
  • Study details: Participants will undergo procedures using the investigational access system to assess its safety and effectiveness in treating brain conditions.
Updated on 19 Feb 2024. Study ID: 1501530163

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team